Dexcom Releases Data Supporting CGMs as Standard of Care for Type 2
Dexcom released data at ADA 2026 showing Dexcom G7 improves glucose levels for people with type 2 diabetes compared to those using traditional blood glucose tests.
MiniMed Systems to Integrate with Abbott’s Dual Glucose-Ketone Sensor
MiniMed is expanding its Abbott partnership to bring continuous ketone data into its pumps and smart insulin pens, potentially adding an earlier warning layer for DKA risk.
The twiist insiights App Now Sends Alerts to Followers
The twiist insiights app updates come on the heels of several new twiist updates including alerts for followers, snooze options, sleep schedules, and more.
Medical Device Correction Issued for Omnipod 5, DASH, Eros Pod Leaks
An estimated 7 million pods fall within the scope of this correction, in the U.S. and international markets, representing about 8.5% of 2025 global Pod production.
Dexcom Warns Users of Stolen Scrapped G7 Sensors on the Market
Dexcom is urging patients and pharmacies to check lot numbers after two batches of scrapped CGM sensors were reportedly stolen and sold through a third party.
Dexcom Unveils Smaller Dexcom G8 CGM with Adaptive Accuracy Tech
Dexcom’s next-gen G8 CGM is 50% smaller than the G7, last 15 days, and use self-adapting tech designed to improve accuracy. The company also teased future multi-analyte monitoring for potassium and ketones.
Insulet Begins Pivotal Study of Fully Closed-Loop Omnipod for Type 2
Insulet has enrolled its first participant in its EVOLVE trial testing an automated system designed to eliminate mealtime bolus announcements for people with type 2 diabetes.
